Literature DB >> 6310004

A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.

L Gutmann, R Williamson.   

Abstract

Addition of beta-lactamase to cultures of antibiotic-sensitive Escherichia coli protected the bacteria against lysis induced by either a hydrolyzable (cephalothin) or relatively nonhydrolyzable (ceftriaxone) cephalosporin. The later addition of a nonhydrolyzable, non-lysis-inducing beta-lactam antibiotic (oxacillin), which had a higher affinity for the beta-lactamase than ceftriaxone, allowed the reversal of the protection and the onset of lysis. These results suggest that trapping of the antibiotic by the enzyme, without significant hydrolysis, is a reversible process that may play a role in the resistance of some gram-negative bacteria to third-generation cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310004     DOI: 10.1093/infdis/148.2.316

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Effect of the 3'-leaving group on turnover of cephem antibiotics by a class C beta-lactamase.

Authors:  L J Mazzella; R F Pratt
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 2.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 3.  Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

Authors:  J L Ho; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Third generation cephalosporins--a panacea for intensive care patients?

Authors:  F A Waldvogel
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

5.  Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.

Authors:  F Bellido; J C Pechère; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 6.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

Review 7.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

8.  Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.

Authors:  D J Phelps; D D Carlton; C A Farrell; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

9.  Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.

Authors:  Wil H F Goessens; Akke K van der Bij; Ria van Boxtel; Johann D D Pitout; Peter van Ulsen; Damian C Melles; Jan Tommassen
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

10.  Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.

Authors:  A S Bayer; M Selecky; K Babel; L Hirano; J Yih; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.